Microbiology Diagnostic Devices And Equipment Market Definition And Segments
Microbiology diagnostics devices and equipment are a broad category covering all kinds of items used in microbiology laboratories and used to diagnose infectious diseases by examining pathogens. These devices and equipment included microscopes, slides, test tubes, Petri dishes, growth media (liquid and solid), inoculation loops, pipettes, and tips, incubators, autoclaves, and laminar flow hoods. Some pieces of equipment are permanent, like microscopes and hoods, while others are not, like pipette tips.
The main types of microbiology diagnostic devices and equipment are laboratory instruments, microbiology analyzers, and reagents and consumables. Laboratory instruments are types of instruments such as incubators, gram stainers, bacterial colony counters, petri dish fillers, and automated culture systems that are needed for operations in the laboratories. The reagents are pathogen-specific kits, and general reagents used in various end-users such as diagnostic laboratories, hospitals, and others.
The microbiology diagnostic devices and equipment market covered in this report is segmented –
1) By Type: Laboratory Instruments, Microbiology Analyzers, Reagents And Consumables
2) By Reagents: Pathogen-Specific Kits, General Reagents
3) By End-User: Diagnostic Laboratories, Hospitals, Other End-Users
Sub segments: Incubators, Gram Strainers, Bacterial Colony Counters, Petri Dish Fillers, Automated Culture Systems, Other Laboratory Instruments, Microscopes, Mass Spectrometers, Other Microbiology Analyzers, Oncology, Hormonal Disorder, Glaucoma, Other Therapeutic Applications
The microbiology diagnostic devices and equipment market size has grown rapidly in recent years. It will grow from $4.49 billion in 2023 to $5.02 billion in 2024 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to increased healthcare expenditure, emerging markets growth, rapid technological advances, rapid growth in aging population and the emergence of novel pathogenic infestations.
The microbiology diagnostic devices and equipment market size is expected to see rapid growth in the next few years. It will grow to $7.74 billion in 2028 at a compound annual growth rate (CAGR) of 11.4%. The growth in the forecast period can be attributed to rise in funding, aging population, an increase in healthcare access and a rapid rise in various bacterial and viral epidemics. Major trends in the forecast period include growing adoption of predictive diagnostics, automation in the field of microbiology diagnostics, next generation microbial testing and increasing mergers and acquisitions.
Surge In Funding And Investments Accelerates Growth In The Microbiology Diagnostic Devices Market
Increasing funding of public and private investments in medical devices is driving the growth of the microbiology diagnostic devices market. Increasing Investments indicate the rising confidence of various private and public players on microbiology diagnostic devices, thereby indicating a progressive increase and stimulating growth. For instance, according to MedTech news, a publisher of news related to medical technology, private equity industry invested $111.8 B (c.$ 151 B) in healthTech industry. Furthermore, globally 96 deals valued at $40.8 billion were completed in medTech vertical. The increasing investments in digital health technologies, artificial intelligence and non-invasive monitoring capability, delivery of gene therapy and regenerative medicines technologies, and customized 3D printing of medical devices are expected to drive the microbiology diagnostic devices market.
The Surging Prevalence Of Chronic Diseases As A Catalyst For Growth In The Microbiology Diagnostic Devices And Equipment Market
The increasing prevalence of chronic disease is expected to propel the growth of the microbiology diagnostic devices and equipment market going forward. A chronic disease is a long-lasting or persistent medical condition that typically develops slowly and lasts for an extended period, often throughout a person's life. Microbiology diagnostic devices and equipment play a crucial role in managing chronic diseases by aiding in the detection, treatment, and prevention of microbial infections and complications associated with these conditions. For instance, in September 2022, according to the World Health Organization (WHO), a Switzerland-based intergovernmental organization, each year there are 41 million deaths worldwide, accounting for 74% of all fatalities attributed to chronic diseases. This includes 17.9 million deaths from cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Therefore, the increasing prevalence of chronic disease is driving the growth of the microbiology diagnostic devices and equipment market.
Major companies operating in the microbiology diagnostic devices and equipment market report are Danaher, Abbott Laboratories, Thermo Fisher Scientific, Becton Dickinson and Company, Biomerieux, Bio-Rad Laboratories Inc., Roche, Bruker Corporation, Charles River Laboratories International Inc., Merck KGaA, Johnson & Johnson, Simens Healthcare, Beckman Coulter Inc., Ortho Clinical Diagnostics, Sysmex Corporation, Siemens Healthineers, TestLine Clinical Diagnostics s.r.o., Cepheid, Hologic, Bayer AG, Cantel Medical Corporation, Meridian Bioscience, Qiagen N.V., Immunodiagnostic Systems Holdings PLC, Mesa Biotech Inc., PerkinElmer, Inc., Adavium Medical, DK Diagnostics, Crosmed, Ortopedia Alemana, Simed, Shalina Healthcare, Elixir Medical Equipment LLC (EME), Matrix Medical, Gulf Medical Co, Almarfa Medical, Lithotech Medical, Neogen Corporation
Regulatory Challenges Impede Progress In The Microbiology Diagnostic Devices Market
Unfavorable regulatory scenarios are major restraints in the microbiology diagnosis devices market. In the US, section 510(k) of the Food, Drug, and Cosmetic Act states that every device manufacturer must register with FDA and notify their intent to market a medical device at least 90 days in advance. These pre-market notifications are considered to be lengthy, rigorous, and time-consuming processes for the approval of medical devices. If in case the submission fails due to some uncertainty, the company has to reperform all the tests and resubmit the premarket approval application. For instance, a 'Vertical Autoclave', a microbiology diagnostic device, complies with the strict international directives and standards such as the capacity of 80-120 liter autoclave chamber volume, low sensitivity loads, restrictions on temperature calibration, and a certificate from ISO17025 accreditation lab for temperature, pressure gauges & timer.
Next-Generation Sequencing Revolutionizes Microbiology Diagnostic Devices Market
Next-Generation Sequencing (NGS) technologies are increasing their prevalence in the microbiology diagnostic devices market due to their cost effectiveness, sensitivity to detect low-frequency variants, and comprehensive genomic coverage. Next-Generation Sequencing (NGS) or high throughput sequencing or Massively Parallel Sequencing (MPS) is a method of sequencing genomes with the ability to sequence hundreds to thousands of genes or gene regions and the capability to detect novel resistance genes (ARG) in bacteria. BioMérieux partnered with Illumina to develop bioMérieux EpiSe, an NGS service that will facilitate epidemiological monitoring of bacterial infections and monitor outbreaks in hospitals. Some of the modern next-generation sequencing technologies that help to sequence DNA and RNA include Illumina (Solexa) sequencing, Roche 454 sequencing, Ion torrent Proton / PGM sequencing, and SOLiD sequencing.
Innovative Third-Generation Total Lab Automation Systems In Microbiology Diagnostics
Major companies operating in the microbiology diagnostic devices and equipment market are developing innovative systems, such as third-generation total lab automation (TLA) systems, to improve the efficiency and accuracy of laboratory testing and reduce the cost of laboratory testing. The third-generation total lab automation (TLA) systems are the most advanced type of TLA system available today. They are designed to automate a wide range of laboratory tasks, from specimen processing and plating to incubation, imaging, and culture reading. For instance, in January 2023, Becton, Dickinson, and Company (BD), a US-based medical device company, launched third-generation total lab automation (TLA) systems. It is a modular system that can be customized to automate a variety of tasks in a microbiology laboratory. It features a modular design, incorporates a robotic track system, offers advanced informatics solutions, and integrates artificial intelligence (AI). Moreover, it is a valuable tool for laboratories that are looking to improve their efficiency, reduce costs, and deliver better patient care.
DCN Dx Bolsters Its Point-Of-Use Testing Capabilities With Acquisition Of Biomed Diagnostics
In April 2022, DCN Dx, a US-based manufacturer and developer of point-of-use tests, acquired Biomed Diagnostics for an undisclosed amount. The acquisition would expand DCN Dx’s footprint in the vertical of point-of-use testing and sampling markets for both humans and animals. Biomed Diagnostics is a US-based microbiological testing company.
North America was the largest region in the microbiology diagnostics devices and equipment market in 2023. Asia-Pacific was the second largest region in the global microbiology diagnostic devices and equipment market. The regions covered in the microbiology diagnostic devices and equipment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The countries covered in the microbiology diagnostic devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain
The microbiology diagnostic devices and equipment consists of sales of instruments such as incubators, autoclave sterilizers, anaerobic culture systems, blood culture systems, gram strainers, microscopes, mass spectrometers, molecular diagnostic instruments, reagents pathogen-specific kits, and general reagents for microbiology diagnostic. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
The microbiology diagnostics devices and equipment market research report is one of a series of new reports from The Business Research Company that provides microbiology diagnostics devices and equipment market statistics, including microbiology diagnostics devices and equipment industry global market size, regional shares, competitors with a microbiology diagnostics devices and equipment market share, detailed microbiology diagnostics devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the microbiology diagnostics devices and equipment industry. This microbiology diagnostics devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.